Team

Management

Ken Cawkell, LLB

CEO, Corporate Secretary and Director

Ken Cawkell, LLB

CEO, Corporate Secretary and Director

Mr. Cawkell has been involved for over 25 years in the biotech industry as both a professional advisor, investor and as the founding principal of Alpha Cognition and its predecessor the Neurodyn Group. He is a member of the British Columbia Bar Association and in 1987, he co-founded the law firm Cawkell Brodie LLP. Mr. Cawkell has gained extensive strategic and development experience and has a history of value creation, as a result of his long-term association with numerous public and private companies. He has been involved in several successful exits and currently sits on the Board of TSE listed Well Health Technologies a leading integrated health care provider. He is a past member of the National Research Council of Canada IMB/INH Advisory Board and a number of biotech industry associations.

Fred Sancilio, MS, PhD

President and Director

Fred Sancilio, MS, PhD

President and Director

Dr. Sancilio has over 35 years of experience in pharmaceutical development and research. He has founded several biopharmaceutical companies including aaiPharma (CDMO renamed Alcami), Endeavor Pharmaceuticals (acquired by Barr Laboratories now Teva) and Aesgen, Inc. (now owned by Pfizer). Dr. Sancilio has been a board member of both public and private pharmaceutical companies and served as an advisor to Comvest Partners and Noble Financial Corporation; investment banking and investment organizations. More recently, he served as Research Professor at Florida Atlantic University. He was elected as a member of Sigma Xi, the Scientific Research Society of North America and holds both a Masters and Doctorate from Rutgers the State University of New Jersey.

Denis Kay, MSc, PhD

Chief Scientific Officer

Denis Kay, MSc, PhD

Chief Scientific Officer

Dr. Kay founded NLS in August 2006 and has acted as NLS’s Chief Scientific Officer for the last 14 years and ACI’s Chief Scientific Officer since 2017. Dr. Kay has more than 25 years of experience in the development and characterization of neurological conditions. He is a grant recipient of the Michael J. Fox Foundation and has received funding from numerous agencies for research and product development programs. Dr. Kay is a graduate of Dalhousie (B.Sc. and M.Sc.) and McGill (Ph.D.) Universities and has contributed publications to over 40 scientific journals. Dr. Kay also held teaching assistantship positions at Dalhousie and McGill Universities, and was a lecturer at McGill University.

Jeremy Wright, BA

Chief Financial Officer

Jeremy Wright, BA

Chief Financial Officer

Mr. Wright has broad experience working with senior management developing strategies and solutions to business issues mainly related to corporate finance, cost and risk management, and governance. Mr. Wright is a Chartered Professional Accountant (Certified Management Accountant), currently serves as President and CEO of Seatrend Strategy Group and as a director for several public and private companies including: Pontus Protein Ltd., Centurion Minerals Ltd., and Demetra Minerals Inc. Mr. Wright previously served as a director of TGS Esports Inc., Freeform Capital Partners Inc., Pacific Community Resources Society and the Canadian Freestyle Ski Association. In addition, Mr. Wright also serves as the CFO for several public and private companies, including: the Target Company, Portofino Resources Inc., and Centurion Minerals Ltd. He was previously the CFO for GTEC Cannabis Co., an ultra-premium cannabis producer having three federally licensed production facilities across Canada. Mr. Wright also holds a Bachelor of Arts, with honours in Environmental Economics, from Brock University.

Directors

Len Mertz, BBA, MPA

Chairman

Len Mertz, BBA, MPA

Chairman

Mr. Mertz has over 35 years of experience as a CEO, board member, and investor in various venture-backed companies including Triumvira Immunologics, Akido Labs, and PeraHealth, of which he is chairman. In addition, he is Chairman of Shannon West Texas Memorial Hospital, a CMS rated 5-star hospital, with currently budgeted gross revenues exceeding $1 billion and he serves on the board of the First National Bank of Mertzon . Mr. Mertz is a cofounder of Mayne & Mertz, Inc. an oil & gas exploration company. He began his career as a certified public accountant and obtained his BBA in Finance with Highest Honors and his Masters in Professional Accounting both from the University of Texas at Austin.

John Havens, BS

Director

John Havens, BS

Director

Mr. Havens received his geology degree from Louisiana State University and has been the President of Seismic Exchange Inc. for over 40 years. SEI is a source for premium 2D and 3D seismic data for the upstream oil and gas industry and is the largest 2D seismic data owner and one of the largest 3D seismic data owners in North America. Mr. Havens is also the owner of a health spa in California and the owner of the Vista Valley Country Club. Mr. Havens has also served on the board of directors of The Fay School, Houston Oaks Club, Cal-a-Vie Health Spa and as Chairman-Elect of the YPO Gold Houston Chapter.

Phillip Mertz, AB

Director

Phillip Mertz, AB

Director

Mr. Mertz is a co-founder and partner of Cenizas Capital, an investment firm focused on public and private equity. In addition to the Target Company, he is an initial investor and board member of Secure Open Solutions, a cybersecurity firm that provides compliance services to defense contractors. He also co-founded Py Square, a software development company that makes practical software solutions for the legal industry, and he is a partner in the investment group, Mertz Holdings. Previously he led business development for a natural gas fuel start-up, CNG Energy, and worked as a management consultant with Touchstone Consulting Group in Washington D.C. He graduated from Harvard University in 2006 with an A.B. in economics.

Rajeev ‘Rob’ Bakshi, BBA

Director

Rajeev ‘Rob’ Bakshi, BBA

Director

Mr. Bakshi was the co-founder of technology company, Silent Witness Enterprises Ltd., which was listed on the TSX and NASDAQ. He oversaw the company’s growth strategy before being sold to Honeywell for approximately $90 million in 2003. Since then, he has been involved with industrial land development, building a Convention Centre in Calgary and other strategic investments. In 2009, Mr. Bakshi began working with a South Korean company to establish Apivio Systems Inc. He led the strategy to turn the business into a Canadian company, putting together an independent board of directors, financing, and corporate governance in his capacity of Executive Chairman. In 2013, he was appointed CEO and was responsible for taking the company public. Apivio Systems Inc. was acquired by Nuri Telecom Company in an all-cash transaction in the spring of 2017.

Ken Cawkell, LLB

CEO, Corporate Secretary and Founder

Ken Cawkell, LLB

CEO, Corporate Secretary and Founder

Mr. Cawkell has been involved for over 25 years in the biotech industry as both a professional advisor, investor and as the founding principal of Alpha Cognition and its predecessor the Neurodyn Group. He is a member of the British Columbia Bar Association and in 1987, he co-founded the law firm Cawkell Brodie LLP. Mr. Cawkell has gained extensive strategic and development experience and has a history of value creation, as a result of his long-term association with numerous public and private companies. He has been involved in several successful exits and currently sits on the Board of TSE listed Well Health Technologies a leading integrated health care provider. He is a past member of the National Research Council of Canada IMB/INH Advisory Board and a number of biotech industry associations.

Dr. Frederick Sancilio, MS,PhD

President and Director

Dr. Frederick Sancilio, MS,PhD

President and Director

Dr. Sancilio has over 35 years of experience in pharmaceutical development and research. He has founded several biopharmaceutical companies including aaiPharma (CDMO renamed Alcami), Endeavor Pharmaceuticals (acquired by Barr Laboratories now Teva) and Aesgen, Inc. (now owned by Pfizer). Dr. Sancilio has been a board member of both public and private pharmaceutical companies and served as an advisor to Comvest Partners and Noble Financial Corporation; investment banking and investment organizations. More recently, he served as Research Professor at Florida Atlantic University. He was elected as a member of Sigma Xi, the Scientific Research Society of North America and holds both a Masters and Doctorate from Rutgers the State University of New Jersey.

Corporate

Read More

Latest News

View All

TSX-V: ACI

15 min delay
Last$21.67
Change$-0.41
Open21.46
Vol909746
High21.94
Low21.16
Stock Information